Metraipolis › archive › dc_e83e47f1886f

Immune checkpoint inhibitor-related myocarditis during DUO-E regimen for endometrial cancer: The first case report in gynecologic oncology — Europe PMC PMID:41169954

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41169954
DOI
10.1016/j.gore.2025.101924
License (as archived)
solo-consultazione
Archived
2026-11-10T11:34:27.362Z
SHA-256 of the archived text
35f74232ee1aee0d9a89c542bdab5b1f794ade01ee60a87e62c130277add9ae0
Stable URL of this page
https://metraipolis.com/documento/dc_e83e47f1886f

How to cite

Immune checkpoint inhibitor-related myocarditis during DUO-E regimen for endometrial cancer: The first case report in gynecologic oncology — Europe PMC PMID:41169954 — Europe PMC (en), https://europepmc.org/article/MED/41169954 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e83e47f1886f (Metraipolis archive dc_e83e47f1886f, sha256 35f74232ee1aee0d9a89c542bdab5b1f794ade01ee60a87e62c130277add9ae0)
BibTeX
@misc{dce83e47f1886f,
  title = {Immune checkpoint inhibitor-related myocarditis during DUO-E regimen for endometrial cancer: The first case report in gynecologic oncology — Europe PMC PMID:41169954},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41169954},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e83e47f1886f; sha256 35f74232ee1aee0d9a89c542bdab5b1f794ade01ee60a87e62c130277add9ae0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41169954. Agents can read the archived copy with the MCP tool read_document.